Plain-English translation of NCT04890483 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called transcranial direct current stimulation (tDCS), which uses gentle electrical currents applied to the scalp to stimulate brain activity. Researchers want to see if tDCS can safely help people with autoimmune rheumatic diseases who are still struggling with fatigue and body pain months after having COVID-19. The treatment is non-invasive, meaning nothing is inserted into your body.
Many people with autoimmune diseases continue to experience severe fatigue and pain long after recovering from COVID-19, and current treatments don't always help. Doctors are exploring whether this brain stimulation technique might offer relief for these lingering symptoms in this specific patient population.
You likely qualify if…
You likely don't qualify if…
You would receive tDCS treatment sessions over the course of one week at the research center. During each session, electrodes are placed on your scalp and mild electrical currents are applied—the procedure is painless and non-invasive. Researchers will monitor your safety and assess whether your fatigue and pain improve during and after the week of treatment.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Brazil